Containing Cefoxitin Costs through a Program to Curtail Use in Surgical Prophylaxis

Affiliations

Geoffrey Taylor: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada
Edith Blondel-Hill: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada
Pamela Kibsey: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada
Erwin Friesen: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada
Ronald Tisdell: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada
Wendy Vaudry: Departments of Medicine, Pediatrics, Laboratory Medicine, and Pharmacy, University of Alberta Hospitals, Edmonton, Alberta, Canada

Abstract

Objective: To reduce drug costs attributable to anti-anaerobic cephalosporins – specifically to reduce cefoxitin use in surgical prophylaxis.

ISSN: 1180-2332 (Print)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://onlinelibrary.wiley.com/journal/9575